Stock BMRN BIOMARIN PHARMACEUTICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart BioMarin Pharmaceutical Inc.

Equities

BMRN

US09061G1013

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
80.91 USD -1.53% Intraday chart for BioMarin Pharmaceutical Inc. -8.71% -16.09%
04-25 Scotiabank Adjusts Price Target on BioMarin Pharmaceutical to $85 From $83, Maintains Sector Perform Rating MT
04-25 Wells Fargo Adjusts Price Target on BioMarin Pharmaceutical to $110 From $100, Maintains Overweight Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 15.36B
CSL LIMITED Stock CSL Limited
 86.13B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 39.82B
BIOGEN INC. Stock Biogen Inc.
 30.42B
UCB Stock UCB
 25.23B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
 11.95B
  1. Stock Market
  2. Equities
  3. BMRN Stock
  4. Charts BioMarin Pharmaceutical Inc.
  5. Sector Chart